Florida Breckenridge, Inc. v. Solvay Pharmaceuticals
United States Court of Appeals for the Eleventh Circuit
174 F.3d 1227 (1999)
Florida Breckenridge, Inc. (plaintiff) manufactured and marketed a menopause hormone drug, Menogen, claiming it was the generic equivalent of Estratest, which was manufactured by Solvay Pharmaceuticals (defendant). Neither Breckenridge nor Solvay had obtained Food and Drug Administration (FDA) approval to market its drug though each erroneously claimed different numerous exemptions under the Drug Efficacy Study Implementation (DESI) program and GRASE-exemption. Solvay notified Breckenridge that it believed that Menogen infringed Estratest’s trade dress and falsely advertised that Menogen was the generic equivalent of Estratest. Breckenridge filed suit for a declaratory judgment that their marketing of Menogen did not infringe Estratest’s trade dress or constitute false advertising under the Lanham Act, a federal law that provides a claim against a competitor for false advertising when it may result in consumer confusion. Solvay counterclaimed for trade-dress infringement and false advertising under the Lanham Act. After discovery, the district court granted summary judgment for Breckenridge on both claims after finding no likelihood of confusion and that a lesser standard of equivalence applied because both drugs were allowed on the market without FDA approval. Solvay appealed, and when the FDA filed an amicus curiae brief contending that neither drug was legally on the market and the appellate court asked the parties to submit supplemental briefs addressing whether Lanham-Act relief is available for drugs sold in violation of FDA rules and regulations, Solvay moved to dismiss the appeal and Breckenridge did not oppose the motion.
Rule of Law
Holding and Reasoning (Per curiam)
What to do next…
Unlock this case brief with a free (no-commitment) trial membership of Quimbee.
You’ll be in good company: Quimbee is one of the most widely used and trusted sites for law students, serving more than 707,000 law students since 2011. Some law schools—such as Yale, Berkeley, and Northwestern—even subscribe directly to Quimbee for all their law students.Unlock this case briefRead our student testimonials
Learn more about Quimbee’s unique (and proven) approach to achieving great grades at law school.
Quimbee is a company hell-bent on one thing: helping you get an “A” in every course you take in law school, so you can graduate at the top of your class and get a high-paying law job. We’re not just a study aid for law students; we’re the study aid for law students.Learn about our approachRead more about Quimbee
Here's why 707,000 law students have relied on our case briefs:
- Written by law professors and practitioners, not other law students. 44,500 briefs, keyed to 983 casebooks. Top-notch customer support.
- The right amount of information, includes the facts, issues, rule of law, holding and reasoning, and any concurrences and dissents.
- Access in your classes, works on your mobile and tablet. Massive library of related video lessons and high quality multiple-choice questions.
- Easy to use, uniform format for every case brief. Written in plain English, not in legalese. Our briefs summarize and simplify; they don’t just repeat the court’s language.